JPH1099087A5 - - Google Patents
Info
- Publication number
- JPH1099087A5 JPH1099087A5 JP1997167838A JP16783897A JPH1099087A5 JP H1099087 A5 JPH1099087 A5 JP H1099087A5 JP 1997167838 A JP1997167838 A JP 1997167838A JP 16783897 A JP16783897 A JP 16783897A JP H1099087 A5 JPH1099087 A5 JP H1099087A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- polynucleotide
- cell
- receptor
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1794996P | 1996-05-20 | 1996-05-20 | |
| US2034496P | 1996-05-23 | 1996-05-23 | |
| US1896196P | 1996-06-05 | 1996-06-05 | |
| US60/020344 | 1996-06-05 | ||
| US60/018961 | 1996-06-05 | ||
| US60/017949 | 1996-06-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH1099087A JPH1099087A (ja) | 1998-04-21 |
| JPH1099087A5 true JPH1099087A5 (enExample) | 2005-04-07 |
Family
ID=27360935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9167838A Withdrawn JPH1099087A (ja) | 1996-05-20 | 1997-05-20 | インターロイキン−１ベータ転換酵素様アポプロシス性プロテアーゼ−６ |
Country Status (2)
| Country | Link |
|---|---|
| US (3) | US6010878A (enExample) |
| JP (1) | JPH1099087A (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6010878A (en) * | 1996-05-20 | 2000-01-04 | Smithkline Beecham Corporation | Interleukin-1 β converting enzyme like apoptotic protease-6 |
| US6455296B2 (en) * | 1997-05-29 | 2002-09-24 | Thomas Jefferson University | Apoptotic protease Mch6, nucleic acids encoding same and methods of use |
| DE69937638T2 (de) * | 1998-06-02 | 2008-10-30 | Vertex Pharmaceuticals Inc., Cambridge | Caspase-9 defiziente tiere und deren verwendung |
| US20030078211A1 (en) * | 1998-06-24 | 2003-04-24 | Merck & Co., Inc. | Compositions and methods for inhibiting bone resorption |
| US6492170B1 (en) * | 2000-09-11 | 2002-12-10 | Isis Pharmaceuticals, Inc. | Antisense modulation of caspase 9 expression |
| EP1283052A1 (en) * | 2001-08-10 | 2003-02-12 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Pharmaceutical composition containing caspase-8 and /or caspase-9 useful for overcoming glucocorticoid- and cancer therapy-induced apoptosis of tumours |
| US7048922B2 (en) * | 2002-05-29 | 2006-05-23 | Demao Yang | Stimulation of hematopoiesis by ex vivo activated immune cells |
| US7332158B2 (en) * | 2002-05-29 | 2008-02-19 | Demao Yang | Compositions and treatments for myelosuppression by ex vivo activated immune cells |
| US20060057121A1 (en) * | 2004-09-10 | 2006-03-16 | Demao Yang | Compositions and treatments using ex vivo activated cells for myelosuppressed patients |
| JP5795341B2 (ja) | 2010-03-08 | 2015-10-14 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | 参照ブロック配列によるｆｕｌｌＣＯＬＤ−ＰＣＲ濃縮 |
| US9089520B2 (en) | 2010-05-21 | 2015-07-28 | Baylor College Of Medicine | Methods for inducing selective apoptosis |
| CA2830361C (en) | 2011-03-31 | 2021-03-16 | Dana-Farber Cancer Institute, Inc. | Methods and compositions to enable multiplex cold-pcr |
| US9434935B2 (en) | 2013-03-10 | 2016-09-06 | Bellicum Pharmaceuticals, Inc. | Modified caspase polypeptides and uses thereof |
| CA2912172A1 (en) | 2013-06-05 | 2014-12-11 | Bellicum Pharmaceuticals, Inc. | Methods for inducing partial apoptosis using caspase polypeptides |
| AU2015341481C1 (en) | 2014-11-03 | 2021-09-16 | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) | T cell receptors directed against Bob1 and uses thereof |
| US11371090B2 (en) | 2016-12-12 | 2022-06-28 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for molecular barcoding of DNA molecules prior to mutation enrichment and/or mutation detection |
| US11174511B2 (en) | 2017-07-24 | 2021-11-16 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for selecting and amplifying DNA targets in a single reaction mixture |
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| US12281166B2 (en) | 2020-05-26 | 2025-04-22 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking Galectin-3 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0593580A4 (en) * | 1991-06-20 | 1995-12-06 | Us Health | Sequences characteristic of human gene transcription product |
| US6010878A (en) * | 1996-05-20 | 2000-01-04 | Smithkline Beecham Corporation | Interleukin-1 β converting enzyme like apoptotic protease-6 |
-
1997
- 1997-05-08 US US08/852,936 patent/US6010878A/en not_active Expired - Fee Related
- 1997-05-20 JP JP9167838A patent/JPH1099087A/ja not_active Withdrawn
-
1999
- 1999-04-27 US US09/300,328 patent/US6294169B1/en not_active Expired - Fee Related
-
2004
- 2004-10-12 US US10/961,148 patent/US7115260B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH1099087A5 (enExample) | ||
| JP2004512022A5 (enExample) | ||
| AU743490B2 (en) | NTN-2 member of TNF ligand family | |
| JP2000312590A5 (enExample) | ||
| US20040110938A1 (en) | Proteins, genes and their use for diagnosis and treatment of schizophrenia | |
| JP2002518010A5 (enExample) | ||
| JP2002521055A5 (enExample) | ||
| JP2014502149A5 (enExample) | ||
| US6030780A (en) | Purified Stat proteins and methods of purifying thereof | |
| JP2004512824A5 (enExample) | ||
| EP0789076A3 (en) | G protein coupled receptor proteins, their production and use | |
| ZA200601900B (en) | Therapeutic uses of chemokine variants | |
| NZ293687A (en) | Alk-7 (activin-like kinase) which is a serine threonine kinase receptor | |
| JP2004501605A5 (enExample) | ||
| US7115567B2 (en) | Purified STAT proteins and methods of purifying thereof | |
| US7070940B2 (en) | Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein | |
| AU5613698A (en) | Vegf-b/receptor complex and uses thereof | |
| KR19990063834A (ko) | 단형 케모킨 베타-8 | |
| Nice et al. | Strategies for the identification and purification of ligands for orphan biomolecules | |
| EP1259818A2 (en) | Diagnosis and treatment of schizophrenia | |
| JP2005528894A5 (enExample) | ||
| JP2006515983A5 (enExample) | ||
| RU2000119129A (ru) | Молекула днк, кодирующая мутантный препронейропептид y, мутантный сигнальный пептид и их применения | |
| JP2006051019A5 (enExample) | ||
| KR970707155A (ko) | 사람 스탄니오칼신-알파(Human stanniocalcin-alpha) |